Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 365

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 365
---
+ years of operational expertise and a strong network of partner laboratories across Latin America, four of which are investors in OmnigenicsAI. This network facilitates rapid and efficient market entry, providing regional labs with localized end -to -endsolutions adapted to market needs without requiring additional investments from partners. • Comprehensive Insights, Precision and Actionable Results: we have accumulated over 114 terabytes of genomic data specific to the Latin American population, one of the most underrepresented groups in global databases. This unique data enables us to deliver more accurate and region -specificinsights. In addition, our tests are designed to provide actionable results that combine genetic, microbiome, epigenetic, and lifestyle data, supporting a more comprehensive, data -drivenapproach to health and wellness. • Localized, Efficient and Accessible Solutions: we prioritize low -cost, high -qualitysolutions, with optimized turnaround times that will be made possible by our wet -labsand streamlined logistics network. This approach enables us to deliver results efficiently and make our services accessible to a wider audience, distinguishing us in a market often dominated by more costly and less regionally adapted services. For example, our products and services will be built on localized genomic datasets, while our results and client services will be provided in Spanish, meeting the specific cultural needs of each market. 189 • Data -Driven Approach and AI Integration: we are building a proprietary, omni -modaldata lake that integrates genomic, microbiome, and lifestyle data. This robust data foundation will fuel our AI capabilities, allowing us to offer precision -basedhealth management and prevention tools specifically tailored to the Latin American population. As AI and next -generationDNA sequencing costs decrease, we are well -positionedto optimize prevention and health management solutions with increasingly sophisticated and cost -effectivetechnologies. • Telemedicine and Localized Support: through our services, we will offer telemedicine consultations with nutrigeneticists and medical geneticists, providing personalized health guidance based on genetic and microbiome insights. Our nutrigeneticists possess in -depthknowledge of local diets and health habits, enabling culturally relevant recommendations. Our telemedicine services will support local health management by connecting customers with qualified experts, reinforcing our commitment to proactive health management in Latin America. We believe that these strengths allow us to compete favorably with other players in our sector. Although many competitors have a longer operating history, larger customer bases, greater brand recognition, or more resources, our unique market positioning, data -drivenapproach, and local partnerships